会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • ONDANSETRON ORALLY DISINTEGRATING TABLET COMPOSITIONS FOR PREVENTION OF NAUSEA AND VOMITING
    • ONDANSETRON ORALLYRON OR DISETEGATING TABLET COMPOSITIONS FOR EVEREN NAUSEA AND VOMITING
    • WO2011066289A1
    • 2011-06-03
    • PCT/US2010/057813
    • 2010-11-23
    • EURAND, INC.VENKATESH, Gopi M.
    • VENKATESH, Gopi M.
    • A01N43/50
    • A61K31/4178A61K9/0056A61K9/2077A61K9/2081A61K9/5026A61K9/5031A61K9/5047A61K9/5078
    • This invention is related to a pharmaceutical composition in the patient-friendly orally disintegrating tablet form comprising a weakly basic, selective serotonin 5-HT3 blocking agent for the prevention of nausea and/or vomiting for up to 24 hrs postdosing in cancer patients prior to undergoing moderately emetogenic chemotherapy or partial or whole body radiotherapy or in subjects at moderate to high risk of postoperative or postdischarge nausea and/or vomiting prior to inpatient or outpatient ambulatory surgery. The unit dosage form comprising a multitude of immediate-release drug particles providing dissolution profiles similar to that of reference drug product, and one or more timed, pulsatile-release bead populations, comprising at least one organic acid, which solubilizes said weakly basic selective serotonin 5-HT3 blocking agent prior to releasing it into the hostile intestinal environment.
    • 本发明涉及一种患者友好的口腔崩解片形式的药物组合物,其包含弱碱性选择性5-羟色胺5-HT 3阻断剂,用于预防恶心和/或呕吐在癌症患者之前多达24小时后进行 中度排卵化疗或部分或全身放射治疗或中度至高风险的患者术后或出院后恶心和/或呕吐在住院或门诊门诊手术之前。 所述单位剂量形式包含大量立即释放的药物颗粒,其提供类似于参考药物产品的溶出曲线,以及一个或多个定时的脉冲释放珠粒群,其包含至少一种有机酸,其溶解所述弱碱性选择性5-羟色胺 5-HT3阻断剂在将其释放到敌对肠道环境中之前。